Answer
The oral solution is licensed with dabrafenib for certain BRAF V600E-mutated gliomas in children aged 1 year and older. The tablet formulation's paediatric safety and efficacy are not established.
Sources for this answer
- Mekinist film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
- Spexotras 0.05 mg/ml powder for oral solution — Current selected SmPCemc · Summary of Product Characteristics